New Breast Cancer Trials for Week of 3/24/14

New trials posted to BCT this week:

• Effect of Tumeric on Breast Tissue in Obese, High-Risk Women (Columbus, OH)
• A Study of How Femara Affects Breast Cancer Cells (Lebanon, NH)
• Ruxolitinib And Taxol in Advanced Triple Negative, Inflammatory Breast Cancer (Boston, MA)
• Palbociclib and an Aromatase Inhibitor for Stage II-III ER+, HER2- Breast Cancer (Boston, MA)
• SGN-LIV1A in HER2-Negative Metastatic Breast Cancer (5 U.S. sites)
• “Rational Dose” Gamma Knife Radiosurgery for Brain Metastases (New Haven, CT)

New Breast Cancer Trials as of 3/13/14

New trials posted to BCT this week:

• A Nutritional Supplement to Improve Cognitive Function in Breast Cancer Survivors (Tampa, FL)
• Scalp Cooling to Prevent Hair Loss Caused By Chemotherapy For Stage I-II Breast Cancer (Houston, TX)
• Nivolumab Alone or Combined With Ipilimumab in Triple Negative Advanced Disease (9 U.S. sites)

New Breast Cancer Trials for Week of 3/3/14

New trials posted to BCT this week:

• Acupuncture to Reduce Chemotherapy Related Side Effects in Early-Stage Breast Cancer (Columbus, OH)
• Comparing Kadcyla & Perjeta to Herceptin, Perjeta & a Taxane for HER2+ Breast Cancer (17 U.S. sites)
• BYL719 Plus Femara or Aromasin for Hormone-Sensitive Advanced Breast Cancer (New York, NY)
• Aromasin and Cytoxan for Hormone Sensitive Metastatic Breast Cancer (New York, NY)
• PF-05212384 + Other Drugs for Advanced ER+, HER2+ or Triple Negative Breast Cancer (8 U.S. sites)